USFDA conducts inspection at Lupin’s manufacturing facility in Goa

22 Nov 2025 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at Lupin’s manufacturing facility located at Goa, India. The Inspection was conducted from November 10, 2025 to November 21, 2025 and closed with the issuance of a Form-483 with seven observations.

The company will address the observations and respond to the USFDA within the stipulated timeframe. It is committed to be compliant with CGMP standards across all its facilities.  

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2101.85 9.90 (0.47%)
05-Dec-2025 13:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.55
Dr. Reddys Lab 1278.65
Cipla 1522.35
Zydus Lifesciences 935.00
Lupin 2101.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×